Department of Thoracic Surgery, University Hospitals Leuven, Leuven, Belgium.
Department of Chronic Diseases and Metabolism, Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Lung Transplant Unit, KU Leuven, Leuven, Belgium.
Interact Cardiovasc Thorac Surg. 2022 Oct 10;35(5). doi: 10.1093/icvts/ivac256.
History of anatomical lung resection complicates lung transplantation (LTx). Our aim was to identify indications, intraoperative approach and outcome in these challenging cases in a retrospective multicentre cohort analysis.
Members of the ESTS Lung Transplantation Working Group were invited to submit data on patients undergoing LTx after a previous anatomical native lung resection between January 2005 and July 2020. The primary end point was overall survival (Kaplan-Meier estimation).
Out of 2690 patients at 7 European centres, 26 (1%) patients (14 males; median age 33 years) underwent LTx after a previous anatomical lung resection. The median time from previous lung resection to LTx was 12 years. The most common indications for lung resection were infections (n = 17), emphysema (n = 5), lung tumour (n = 2) and others (n = 2). Bronchiectasis (cystic fibrosis or non-cystic fibrosis related) was the main indication for LTx (n = 21), followed by COPD (n = 5). Two patients with a previous pneumonectomy underwent contralateral single LTx and 1 patient with a previous lobectomy had ipsilateral single LTx. The remaining 23 patients underwent bilateral LTx. Clamshell incision was performed in 12 (46%) patients. Moreover, LTx was possible without extracorporeal life support in 13 (50%) patients. 90-Day mortality was 8% (n = 2) and the median survival was 8.7 years.
The history of anatomical lung resection is rare in LTx candidates. The majority of patients are young and diagnosed with bronchiectasis. Although the numbers were limited, survival after LTx in patients with previous anatomical lung resection, including pneumonectomy, is comparable to reported conventional LTx for bronchiectasis.
解剖性肺切除术的病史会使肺移植(LTx)复杂化。我们的目的是通过回顾性多中心队列分析,确定这些具有挑战性病例的适应证、术中方法和结果。
ESTS 肺移植工作组的成员被邀请提交 2005 年 1 月至 2020 年 7 月期间,在先前进行解剖性原生肺切除术之后接受 LTx 的患者的数据。主要终点是总生存率(Kaplan-Meier 估计)。
在来自 7 个欧洲中心的 2690 例患者中,26 例(1%)患者(14 例男性;中位年龄 33 岁)在先前的肺切除术后接受了 LTx。从先前的肺切除术到 LTx 的中位时间为 12 年。肺切除术的最常见适应证是感染(n=17)、肺气肿(n=5)、肺部肿瘤(n=2)和其他疾病(n=2)。支气管扩张症(囊性纤维化或非囊性纤维化相关)是 LTx 的主要适应证(n=21),其次是 COPD(n=5)。2 例先前接受过肺切除术的患者接受了对侧单肺移植,1 例先前接受过肺叶切除术的患者接受了同侧单肺移植。其余 23 例患者接受了双侧 LTx。12 例(46%)患者行 Clamshell 切口。此外,在 13 例(50%)患者中无需体外生命支持即可进行 LTx。90 天死亡率为 8%(n=2),中位生存时间为 8.7 年。
解剖性肺切除术的病史在 LTx 候选者中很少见。大多数患者为年轻人,且被诊断为支气管扩张症。尽管数量有限,但在先前接受过解剖性肺切除术(包括肺切除术)的患者中进行 LTx 的生存率与报告的支气管扩张症常规 LTx 相当。